UPDATE (Feb. 2011)
Months ago, I discussed the 2009 release of a generic to Subutex which is now available by 2 companies. I had expected a Suboxone combination generic to be on the market by now, as the exlusive patent had expired. With the release of the new Film product, the situation has become unclear and I feel the need to clarify any misleading information.
After the release and seubsequent success of Suboxone Film, the status on any upcoming generics for Suboxone combination tablets remains ambiguous. According to many Doctors, it is not likely that a generic will be released any time soon; however the logic behin that statement is unknown to me. What we do know is that Reckitt Benckiser has a NEW patent for the Film product, which will not expire for a while now. The company has also heavily discouraged use of the tablet form of Suboxone, and pushing the Film form as superior, with less risk of diversion and misuse (which was never really a problem anyway).
Obviously, the company would like to scar the reputation of the tablet form, as any generic version represents a threat to sales; however Suboxone Film largely alleviates this concern, serving as a future source of 'damage control' for any potential losses resulting from a generic combination product.
If anyone knows whether Reckitt has extended the patent for the original Suboxone Tablet, please comment the blog or contact me with a cited source.
Providing straightforward information pertaining to drugs, drug use & drug policy. The Grey Pages promotes drug-related literacy and advocates a system of viable and tolerant drug policies. This is my personal collection of commentaries, essays, tid-bits, and other such writings on everything ranging from drug use, drug policy and drug-myths, to drug-science, addiction, human behavior, and the workings of the human brain. I started this blog with a particular focus on opioids, and over the past year have found my interest gravitate toward the intriguing, ever-changing world of designer intoxicants (i.e. "research chemicals" or "designer drugs").